MMR and Varicella Immunization Rate During Dupilumab Therapy

Current FDA guidance is to pause administration of live vaccinations during dupilumab therapy. It is currently unknown whether this recommendation results in delayed vaccination.
Source: Journal of Allergy and Clinical Immunology - Category: Allergy & Immunology Authors: Source Type: research